Skip to main content

Avenue Capital Group — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

28
Companies
$1.7B
Total invested
$45.6M
Avg. check
43
Industries
Biotechnology 6Medical Device 5Health Care 5Media and Entertainment 3Sports 3Biopharma 3+37 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 28
Epica International
September 2024

Epica International designs, develops, and distributes progressive robotic systems.

Health Diagnostics · San Clemente$13.5M Debt Financing
Oliver Space
August 2022

Oliver Space assists with furnishing its clients homes through its room building and room furnishing service.

Furniture · San Francisco$36.0M Series B
BioVie
August 2025

BioVie specializes in the development of innovative solutions for the treatment of neurodegenerative and liver diseases.

Biotechnology · Beverly$12.0M Post-IPO Equity
Unrivaled
August 2026

Unrivaled is a women’s basketball league that provides an off-season platform for elite athletes to play.

Basketball · Miami$106.3M Series C
Cytocom
July 2021

Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.

Biopharma · Fort Collins$75.0M Post-IPO Equity
Cosm
June 2026

Cosm is a media and entertainment company that builds end-to-end experience solutions for the technology and entertainment sectors.

Content · Los Angeles$100.0M Series C
Eyenovia
May 2026

Eyenovia is a biopharmaceutical company that provides a portfolio of next generation topical eye treatments.

Biotechnology · New York$10.0M Post-IPO Equity
Citius Oncology
May 2026

Citius Oncology is a pharmaceutical company that provides the development and commercialization of innovative oncology therapies.

Medical · Cranford$25.0M Post-IPO Debt
Ocugen
May 2026

Ocugen is a biotechnology company that develops novel gene and cell therapies to improve health and patient outcomes.

Biopharma · Malvern$115.0M Post-IPO Debt
Quartzy
April 2026

The world’s leading solution for consolidating lab communication, inventory management, and lab supply purchasing.

E-Commerce · HaywardDebt Financing
North Carolina Courage
March 2026

North Carolina Courage is a women's soccer team that competes in the National Women's Soccer League.

Sports · Raleigh$40.0M Private Equity
Turn Therapeutics
March 2026

Turn Therapeutics is a pharmaceutical company that is dedicated to reducing the human and economic costs of infection and skin disease.

Biotechnology · Calabasas$7.0M Post-IPO Debt
Voom Medical Devices
April 2025

Voom Medical Devices offers orthopedic medical devices and appliances.

Health Care · New York$30.0M Series B
CityPickle
June 2024

CityPickle is a pickleball court that offers open play, leagues, and tournaments.

Events · Brooklyn$10.4M Venture - Series Unknown
Third Pole
December 2022

Third Pole develops products that generate and deliver electric nitric oxide for hospital, ambulatory, and home use.

Customer Service · Waltham$32.0M Series B
Men In Blazers
January 2025

Men In Blazers is a soccer-focused media company that covers sports events, leagues, and TV shows.

Broadcasting · New York$15.0M Series A
Beyond Air
January 2026

Beyond Air is a biotechnology company that focuses on the development of drugs for the treatment of lung infections.

Biopharma · Garden City$5.0M Post-IPO Equity
ITS Technology
October 2023

ITS provides IT managed services and hosted telephony solutions for hard to reach rural and urban businesses.

Information Technology · Chester$121.6M Debt Financing
Castlehaven Finance
August 2019

Castlehaven Finance is an alternative lender funding property development in Ireland.

Consulting · Dundrum$280.6M Private Equity

Where Avenue Capital Group invests

Biotechnology6
Medical Device5
Health Care5
Media and Entertainment3
Sports3
Biopharma3

About Avenue Capital Group's portfolio

How many companies has Avenue Capital Group invested in?▸

Avenue Capital Group has invested in 28 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Avenue Capital Group invest in?▸

Avenue Capital Group's top investment sectors include Biotechnology, Medical Device, Health Care, Media and Entertainment, Sports. The firm invests across 43 different industry categories.

What is Avenue Capital Group's largest investment?▸

Among tracked funding rounds, Castlehaven Finance received $280.6M in a Private Equity round. Avenue Capital Group's total known invested capital is $1.7B.

What is the average investment size for Avenue Capital Group?▸

Avenue Capital Group's average investment size is $45.6M across its portfolio of 28 companies.

What are Avenue Capital Group's most recent investments?▸

Recent Avenue Capital Group portfolio additions include Epica International, Oliver Space, BioVie, Unrivaled, Cytocom. These companies were founded in 2020 or later.

Reach the founders behind these 28 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →